Lecour, S;
Schulz, R;
Ferdinandy, P;
Hausenloy, DJ;
(2015)
Platelet inhibitors influence cardioprotection: importance in preclinical study design: reply.
Cardiovasc Res
, 106
(1)
8 - 8.
10.1093/cvr/cvv052.
Preview |
Text
Hausenloy_1465781_Reply.pdf Download (62kB) | Preview |
Abstract
We would like to thank Professors Cohen and Downey for highlighting platelet inhibitors, in particular platelet P2Y12 receptor antagonists, as an important confounder to take into consideration in pre-clinical studies designed to study novel cardioprotective strategies against ischaemia/reperfusion injury.
| Type: | Article |
|---|---|
| Title: | Platelet inhibitors influence cardioprotection: importance in preclinical study design: reply |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/cvr/cvv052 |
| Publisher version: | http://dx.doi.org/10.1093/cvr/cvv052 |
| Language: | English |
| Additional information: | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com. This article has been accepted for publication in Cardiovascular Research Published by Oxford University Press. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1465781 |
Archive Staff Only
 |
View Item |
